Identification of the enzymatic mechanism of nitroglycerin bioactivation
about
An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivationRecent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialNitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic PropertiesOrganic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative StressNitric oxide synthases in heart failureS-nitrosothiols and the S-nitrosoproteome of the cardiovascular systemDevelopment of an on-animal separation-based sensor for monitoring drug metabolism in freely roaming sheepStructural and Functional Consequences of Coenzyme Binding to the Inactive Asian Variant of Mitochondrial Aldehyde Dehydrogenase: ROLES OF RESIDUES 475 AND 487Vascular Bioactivation of Nitroglycerin by Aldehyde Dehydrogenase-2: REACTION INTERMEDIATES REVEALED BY CRYSTALLOGRAPHY AND MASS SPECTROMETRYAldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical applicationCharacterization of the mechanism of cytochrome P450 reductase-cytochrome P450-mediated nitric oxide and nitrosothiol generation from organic nitratesMitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cellsCharacterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.Mitochondrial oxidative stress and nitrate tolerance--comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice.Assessment of endothelial cell function and physiological microcirculatory reserve by video microscopy using a topical acetylcholine and nitroglycerin challenge.Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Synthesis and characterization of a novel organic nitrate NDHP: Role of xanthine oxidoreductase-mediated nitric oxide formation.Mitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemiaAldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?Discovery of novel regulators of aldehyde dehydrogenase isoenzymesNitrates and nitrites in the treatment of ischemic cardiac diseaseAldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cellsAfter 130 years, the molecular mechanism of action of nitroglycerin is revealed.The nitric oxide pathway and possible therapeutic options in pre-eclampsiaDisruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase "Asian" variant.Mitochondrial aldehyde dehydrogenase and cardiac diseases.Mitochondrial aldehyde dehydrogenase mediates vasodilator responses of glyceryl trinitrate and sodium nitrite in the pulmonary vascular bed of the ratThe Reemergence of Nitrite as a Beneficial Agent in the Treatment of Ischemic Cardiovascular DiseasesMitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin.Daily low-dose folic acid supplementation does not prevent nitroglycerin-induced nitric oxide synthase dysfunction and tolerance: a human in vivo study.Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity.Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicityReversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirinMitochondrial aldehyde dehydrogenase prevents ROS-induced vascular contraction in angiotensin-II hypertensive mice.A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena.Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia.
P2860
Q24535741-3EA52F75-31B1-4B3A-91D0-9967A59EF05AQ24605881-8242A777-63B1-4CA6-80F1-58BA45905024Q24656131-0936928E-F0B0-4EA7-9287-3BEEAE4FD86AQ26771830-569F409A-7413-42FB-ACB0-84BE375966F1Q26799354-1B4B4BC5-4EDE-40C3-89F5-BE0F633072AEQ26830146-EF1ACAB7-196A-4DE0-BDD8-F29384CC86C6Q26852676-3D2A6939-3A59-4A1C-8969-3F05D0269AD4Q27336031-EC70CE44-1770-4B5B-A70C-F7238526BF66Q27643918-2BA87F79-67A0-417C-9566-4A3BCDD1F334Q27673375-FF463EEE-6F32-4114-953F-E3E1958C63CDQ28265682-D5269225-3F1C-44C0-9CB7-CBDF0ABDDBA9Q28578867-E1A58FF4-8423-4381-98AA-2632D5FF6C5AQ28582386-E801A9C0-90FE-4968-AEAB-668B29531244Q30596680-15BF5C93-2086-4BF5-96B7-8B904CBD39D7Q33263050-7EB2DFB2-4D5D-4C26-9B75-3495E199B81FQ33704610-DDF15561-79D2-4C71-9331-CB81C91D2D6CQ33707099-5F39A777-17E6-42BC-AA98-8709A32E05F6Q33761211-B3C7D8B0-47CE-4505-AC17-50725BC46B74Q33761296-592AB192-EC5E-4726-8C47-B793C17DC05BQ33763629-4AA3AC43-4C3F-461B-8C4A-42AE3A414657Q33797190-0ED558E3-55E8-4F7F-9DC6-45D189CDB853Q33829318-77EE6BE3-90F7-45EB-A91A-790CA9ABD969Q33910541-57E699AB-7AAB-47A3-B3FF-71937E8C28C6Q34026132-DC1F1413-380A-44FB-8C6A-1F934AFF6A41Q34029878-7EAD7EB8-16F5-40F7-BE76-A9710E2D5E04Q34065261-924B2548-C1DA-46B3-B727-964969281BD6Q34093072-AE90DFEB-46BA-4CAE-BCAA-3EE15E3C23D7Q34113383-CA982BB2-A107-47BD-BDEE-1E71C5758DEAQ34150559-673F67F2-C802-41B6-AF02-D25BEA206D25Q34201601-A22EFA7A-0796-49CE-8633-E727ED5FE789Q34312771-9364453B-1F78-46F9-B0C7-67B96F590C45Q34338622-BC766D7E-9BD3-43E7-8024-FAAF961BBE6BQ34395219-3FCF3C97-4CE0-4874-94FE-BD95E7577F33Q34414890-8C99A5E1-9596-4D10-BC3A-B0FD3682BFCAQ34460615-CD5EA37D-904D-4C3F-A48B-0453F9F0E5F4Q34524690-6706B0A7-E4CE-4212-8F17-0D7F551E50FBQ34574584-7A43990E-A589-4261-AF9F-399BF3E52EEBQ34899768-2BD8D25A-4BDE-4A81-868A-B699735BC0CFQ34989686-045B146A-935D-4C25-9BE9-0F5B5946928CQ35058371-883823A1-CC59-4676-A024-C4052697A16B
P2860
Identification of the enzymatic mechanism of nitroglycerin bioactivation
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@ast
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@en
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@nl
type
label
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@ast
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@en
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@nl
prefLabel
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@ast
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@en
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@nl
P2093
P2860
P356
P1476
Identification of the enzymatic mechanism of nitroglycerin bioactivation
@en
P2093
Jian Zhang
Jonathan S Stamler
Zhiqiang Chen
P2860
P304
P356
10.1073/PNAS.122225199
P407
P577
2002-06-04T00:00:00Z